Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Sativex sublingual cannabis extract spray: Phase II/III started

GWP began a placebo-controlled, U.S. Phase II/III trial of sublingual Sativex

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE